Search

Your search keyword '"Bile Acids and Salts toxicity"' showing total 264 results

Search Constraints

Start Over You searched for: Descriptor "Bile Acids and Salts toxicity" Remove constraint Descriptor: "Bile Acids and Salts toxicity"
264 results on '"Bile Acids and Salts toxicity"'

Search Results

1. Obeticholic acid alleviates intrauterine growth restriction induced by di-ethyl-hexyl phthalate in pregnant female mice by improving bile acid disorder.

2. Establishment of an in vitro cholestasis risk assessment system using two-dimensional cultured HepaRG cells and 12 bile acids.

3. Bile acid- and ethanol-mediated activation of Orai1 damages pancreatic ductal secretion in acute pancreatitis.

5. Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid.

6. Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.

7. Cholesterol Induces Nrf-2- and HIF-1 α -Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis.

8. Facial Amphiphilicity-Induced Polymer Nanostructures for Antimicrobial Applications.

9. Differential toxic effects of bile acid mixtures in isolated mitochondria and physiologically relevant HepaRG cells.

10. Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration.

11. Microbial Metabolites Determine Host Health and the Status of Some Diseases.

12. Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications.

13. Bile salts regulate CYP7A1 expression and elicit a fibrotic response and abnormal lipid production in 3D liver microtissues.

14. Safety, functional properties and technological performance in whey-based media of probiotic candidates from human breast milk.

15. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.

16. Molecular Mechanisms for Protection of Hepatocytes against Bile Salt Cytotoxicity.

17. Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells.

18. Growth and Cell Properties of Modified Lactobacillus plantarum CICC21001 with Supplementing C 18 -FFAs to Growth Medium in vitro.

19. Cholemic nephropathy - Historical notes and novel perspectives.

20. Drug-induced bile duct injury.

21. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.

22. A new method for the in vitro determination of the bile tolerance of potentially probiotic lactobacilli.

23. Structure-Property Relationships in Sodium Muricholate Derivative (Bile Salts) Micellization: The Effect of Conformation of Steroid Skeleton on Hydrophobicity and Micelle Formation-Pattern Recognition and Potential Membranoprotective Properties.

24. Selective inhibition of BET proteins reduces pancreatic damage and systemic inflammation in bile acid- and fatty acid ethyl ester- but not caerulein-induced acute pancreatitis.

25. Activation of NADPH oxidases leads to DNA damage in esophageal cells.

26. Bile acids and their receptors during liver regeneration: "Dangerous protectors".

27. Mechanisms of bile acid mediated inflammation in the liver.

28. Mcl-1 suppresses abasic site repair following bile acid-induced hepatic cellular DNA damage.

29. Characterization of V. cholerae T3SS-dependent cytotoxicity in cultured intestinal epithelial cells.

30. Activation of necroptosis in human and experimental cholestasis.

31. Role of ion transporters in the bile acid-induced esophageal injury.

32. Classification of Cholestatic and Necrotic Hepatotoxicants Using Transcriptomics on Human Precision-Cut Liver Slices.

33. Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.

34. Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes.

35. Bile Acid-Induced Suicidal Erythrocyte Death.

36. Characterization of Colorectal Cancer Development in Apc (min/+) Mice.

37. Development of Bile Salt-Resistant Leuconostoc citreum by Expression of Bile Salt Hydrolase Gene.

38. Prediction of the Clinical Risk of Drug-Induced Cholestatic Liver Injury Using an In Vitro Sandwich Cultured Hepatocyte Assay.

39. Development of an in Silico Profiler for Mitochondrial Toxicity.

40. Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes.

41. Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids.

42. Bioactivity characterization of Lactobacillus strains isolated from dairy products.

43. Secondary bile acids effects in colon pathology. Experimental mice study.

44. Inhibitors of ORAI1 Prevent Cytosolic Calcium-Associated Injury of Human Pancreatic Acinar Cells and Acute Pancreatitis in 3 Mouse Models.

45. Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.

46. In vitro evidence that phosphatidylcholine protects against indomethacin/bile acid-induced injury to cells.

47. Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.

48. In Vitro Properties of Potential Probiotic Indigenous Lactic Acid Bacteria Originating from Traditional Pickles.

49. Histopathologic changes in the middle ear mucosa after exposure to pepsin and unconjugated bile acid.

50. An interfacial and comparative in vitro study of gastrointestinal lipases and Yarrowia lipolytica LIP2 lipase, a candidate for enzyme replacement therapy.

Catalog

Books, media, physical & digital resources